Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Conteúdo fornecido por TheoryLab and American Cancer Society. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por TheoryLab and American Cancer Society ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !
Fique off-line com o app Player FM !
Patient perspectives on de-escalating chemotherapy and comorbidities in breast cancer patients
MP3•Home de episódios
Manage episode 298187510 series 2681705
Conteúdo fornecido por TheoryLab and American Cancer Society. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por TheoryLab and American Cancer Society ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode, two American Cancer Society grantees discuss recent findings related to how breast cancer patients feel about de-escalating chemotherapy as well as a new paper on comorbidities in breast cancer patients. The first half of the conversation is not necessarily technical, but it’s geared for a scientific audience. The second half is a more general discussion for a lay audience. Avonne Connor, PhD, is a breast cancer epidemiologist focused on health disparities research. She is Assistant Professor of Epidemiology and Oncology at the Bloomberg School of Public Health and has a joint appointment at the Sidney Kimmel Comprehensive Cancer Center. She recently published findings in the journal Cancer on “Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer:” https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33530 Gabrielle Rocque, MD, is a breast medical oncologist and health services researcher with an interest in quality and value in health care delivery. She is an Associate Professor of Medicine at The University of Alabama at Birmingham with joint appointments in hematology and oncology as well as gerontology, geriatrics, and palliative care. Her recent paper in Cancer Medicine was on “Patient perspectives on chemotherapy de‐escalation in breast cancer:” https://onlinelibrary.wiley.com/doi/10.1002/cam4.3891 3:02 – Dr. Rocque shares takeaways from her recent study on patients’ “interest in de-escalation trial participation, perceived barriers/facilitators to participation, and language describing de-escalation” 8:44 – How the pandemic influenced patients’ decisions 10:58 – How she became interested in exploring patient perspectives on de-escalating treatment 12:44 – Dr. Connor discusses findings on “associations between newly diagnosed comorbidities and the risk of cardiovascular disease mortality among (breast cancer) patients” 20:36 – Dr. Rocque reacts to the paper and asks, “Where do we go from here in terms of interventions?” 24:40 – On how a cancer diagnosis can prompt patients to reflect on their lives and how they can take care of their health 27:55 – Dr. Connor talks about how rewarding and exciting it is to train a postdoctoral fellow 29:39 – Dr. Rocque on her passion – how do we provide the best supportive care to patients, and how do we integrate research and clinical care? 30:50 – How American Cancer Society funding impacted their research and careers
…
continue reading
139 episódios
MP3•Home de episódios
Manage episode 298187510 series 2681705
Conteúdo fornecido por TheoryLab and American Cancer Society. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por TheoryLab and American Cancer Society ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode, two American Cancer Society grantees discuss recent findings related to how breast cancer patients feel about de-escalating chemotherapy as well as a new paper on comorbidities in breast cancer patients. The first half of the conversation is not necessarily technical, but it’s geared for a scientific audience. The second half is a more general discussion for a lay audience. Avonne Connor, PhD, is a breast cancer epidemiologist focused on health disparities research. She is Assistant Professor of Epidemiology and Oncology at the Bloomberg School of Public Health and has a joint appointment at the Sidney Kimmel Comprehensive Cancer Center. She recently published findings in the journal Cancer on “Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer:” https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33530 Gabrielle Rocque, MD, is a breast medical oncologist and health services researcher with an interest in quality and value in health care delivery. She is an Associate Professor of Medicine at The University of Alabama at Birmingham with joint appointments in hematology and oncology as well as gerontology, geriatrics, and palliative care. Her recent paper in Cancer Medicine was on “Patient perspectives on chemotherapy de‐escalation in breast cancer:” https://onlinelibrary.wiley.com/doi/10.1002/cam4.3891 3:02 – Dr. Rocque shares takeaways from her recent study on patients’ “interest in de-escalation trial participation, perceived barriers/facilitators to participation, and language describing de-escalation” 8:44 – How the pandemic influenced patients’ decisions 10:58 – How she became interested in exploring patient perspectives on de-escalating treatment 12:44 – Dr. Connor discusses findings on “associations between newly diagnosed comorbidities and the risk of cardiovascular disease mortality among (breast cancer) patients” 20:36 – Dr. Rocque reacts to the paper and asks, “Where do we go from here in terms of interventions?” 24:40 – On how a cancer diagnosis can prompt patients to reflect on their lives and how they can take care of their health 27:55 – Dr. Connor talks about how rewarding and exciting it is to train a postdoctoral fellow 29:39 – Dr. Rocque on her passion – how do we provide the best supportive care to patients, and how do we integrate research and clinical care? 30:50 – How American Cancer Society funding impacted their research and careers
…
continue reading
139 episódios
Todos os episódios
×Bem vindo ao Player FM!
O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.